These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19995833

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
    Collongues N, Marignier R, Zéphir H, Blanc F, Vukusic S, Outteryck O, Fleury M, Ruet A, Borgel F, Thouvenot E, Moreau T, Defer G, Derache N, Pelletier J, Audoin B, Debouverie M, Labauge P, Gout O, Camu W, Brassat D, Brochet B, Vermersch P, Confavreux C, de Seze J.
    Mult Scler; 2011 Jun; 17(6):720-4. PubMed ID: 21239412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
    Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M.
    Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
    [Abstract] [Full Text] [Related]

  • 10. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.
    Semin Ophthalmol; 2008 Sep; 23(3):191-200. PubMed ID: 18432545
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of neuromyelitis optica with a pediatric onset.
    Collongues N, Marignier R, Zéphir H, Papeix C, Fontaine B, Blanc F, Rodriguez D, Fleury M, Vukusic S, Pelletier J, Audoin B, Thouvenot E, Camu W, Barroso B, Ruet A, Brochet B, Vermersch P, Confavreux C, de Seze J.
    Neurology; 2010 Sep 21; 75(12):1084-8. PubMed ID: 20855851
    [Abstract] [Full Text] [Related]

  • 12. [Clinical features of NMO according to brain MRI findings].
    Shimizu Y.
    Brain Nerve; 2010 Sep 21; 62(9):933-43. PubMed ID: 20844304
    [Abstract] [Full Text] [Related]

  • 13. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders.
    Cabrera-Gómez J, Saiz-Hinarejos A, Graus F, González-Quevedo A, Rodríguez-Rojas R, Quevedo-Sotolongo L, Real-González Y, Grass-Fernández D, Cristófol-Corominas M, Rodríguez-Cordero M, Robinson-Agramonte M, Infante-Velázquez E, Cabrera-Núñez A, Ugarte-Sánchez C, Jordán-González J, González de la Nuez J, García-Lahera J, Tellez R, Baez-Martín M, Romero-García K.
    Mult Scler; 2008 Mar 21; 14(2):248-51. PubMed ID: 18208893
    [Abstract] [Full Text] [Related]

  • 14. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
    Eichel R, Meiner Z, Abramsky O, Gotkine M.
    Arch Neurol; 2008 Feb 21; 65(2):267-71. PubMed ID: 18268199
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM.
    Neurologist; 2007 Jan 21; 13(1):2-11. PubMed ID: 17215722
    [Abstract] [Full Text] [Related]

  • 16. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG.
    Arch Neurol; 2008 Jan 21; 65(1):78-83. PubMed ID: 18195142
    [Abstract] [Full Text] [Related]

  • 17. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
    Yanagawa K, Kawachi I, Toyoshima Y, Yokoseki A, Arakawa M, Hasegawa A, Ito T, Kojima N, Koike R, Tanaka K, Kosaka T, Tan CF, Kakita A, Okamoto K, Tsujita M, Sakimura K, Takahashi H, Nishizawa M.
    Neurology; 2009 Nov 17; 73(20):1628-37. PubMed ID: 19917985
    [Abstract] [Full Text] [Related]

  • 18. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.
    Brain; 2007 May 17; 130(Pt 5):1235-43. PubMed ID: 17449477
    [Abstract] [Full Text] [Related]

  • 19. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
    Domingos J, Isidoro L, Figueiredo R, Brum M, Capela C, Barros P, Santos E, Macário Mdo C, Pinto Marques J, Pedrosa R, Vale J, Sá MJ.
    Clin Neurol Neurosurg; 2015 Jul 17; 134():79-84. PubMed ID: 25965287
    [Abstract] [Full Text] [Related]

  • 20. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Min JH, Kim HJ, Kim BJ, Lee KW, Sunwoo IN, Kim SM, Kim BJ, Kim SH, Park MS, Waters P, Vincent A, Sung JJ, Lee KH.
    Mult Scler; 2009 Sep 17; 15(9):1069-76. PubMed ID: 19625331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.